bioRxivImmunologyPreprint
MRN-ATM Pathway Activation in CD4 T-Cell Senescence during Chronic Hepatitis B Virus Infection
Xiaoying DengiD, Xiaoyan Wang, Yi LiiD, Fangfang Li, Jun Xiong, Hongyan Shi, Yun ZhouiD, Chuantao YeiD, X H Zheng, Jianqi LianiD, Chao Fan, Ying Zhang
Abstract
T-cell senescence is a hallmark of immune dysfunction in persistent viral infections, characterized by DNA damage accumulation and telomere erosion. However, the mechanisms driving CD4 T-cell senescence in the context of chronic hepatitis B virus (HBV) infection remain poorly defined. In this study, we demonstrated that people with chronic HBV infection exhibited CD4 T-cell senescence, marked by elevated KLRG1, along with increased DNA damage and telomere shortening, compared to HS. Notably, activation of the MRN-ATM (MRE11/RAD50/NBS1-Ataxia Telangiectasia Mutated Protein) pathway was prominent in CD4 T cells from HBV patients. Importantly, suppression of MRN attenuated ATM phosphorylation and its downstream signaling molecules, and inhibition of ATM reduced the production of proinflammatory cytokines in CD4 T cells derived from both HBV patients and HS. These results suggest that in chronic HBV infection, the virus induced CD4 T-cell senescence, telomere erosion, and DNA damage, while concurrent activation of the MRN-ATM pathway may serve as a compensatory mechanism to preserve CD4 T-cell function. Elucidating this relationship between T-cell senescence and DNA damage repair helps to understanding the mechanisms underlying HBV persistence and providing potential therapeutic targets against chronic HBV infection.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4+ T cell responses
Jillian M. Jespersen, Lia Avanesyan, … Jody L. Baron·bioRxiv·Sep 29, 2025
- PD-1 signaling is essential for the early accumulation of HBV-specific CD8+ T cells during HBV infection
Xiaoqing Zeng, Wen Pan, … Jia Liu·bioRxiv·Sep 17, 2025
- Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition
Melanie Urbanek‐Quaing, Yin-Han Chou, … Markus Cornberg·HepatologyPeer-reviewed·Dec 19, 2024
- CD8 T cells with classical and NK-like cytotoxic gene expression programs mediate control of HBV replication and functional cure
Elias Isaac Lattouf, Martin Feuerherd, … Georg M. Lauer·bioRxiv·Jun 29, 2026
- Cytotoxic CD4+ T cells eliminate senescent cells by targeting cytomegalovirus antigen
T. Hasegawa, T. Oka, … S. Demehri·bioRxiv·Mar 6, 2023
- CD4 T Cells Acquire Cytotoxic Properties to Modulate Cellular Senescence and Aging
Y. Elyahu, I. Feygin, … A. Monsonego·bioRxiv·Jan 14, 2024